Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanism of Transposon Silencing in the Brain

Award Number: R21NS145053
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/16/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Mechanism of Transposon Silencing in the Brain - Project Summary/Abstract Transposable elements (TEs), first discovered by Barbara McClintock, are mobile DNA sequences that can relocate within the genome. Once dismissed as “junk” or “selfish” DNA, TEs are now recognized as contributors to both normal development and disease. TEs make up large portions of many genomes, yet their regulation—especially in somatic tissues like the brain—remains poorly understood. Retrotransposons, or Class I elements, mobilize through a copy-and-paste RNA intermediate and remain active in the human germline, brain, and cancers. Notably, retrotransposon activity in neurons can generate somatic mosaicism, contributing to neuronal diversity but also to genome instability. Elevated TE expression has been implicated in several neurodegenerative diseases, including ALS, FTLD, and Alzheimer's disease. In the germline, TEs are repressed by the piRNA pathway, but this system is largely absent in the brain, suggesting the existence of alternative silencing mechanisms. Our preliminary data have identified (a) a novel TE-silencing protein expressed in the adult brain, and (b) that TE loci in the brain are transcriptionally active, unlike in the ovary. We hypothesize that the brain employs distinct, tissue-specific mechanisms to post-transcriptionally silence TEs and preserve neuronal function. The long-term goal of this proposal is to uncover how neurons regulate transposon activity to maintain genome integrity and prevent neurodegeneration. In Aim 1, we will define the mechanism of a newly identified TE silencing protein in the brain. In Aim 2, we will identify and characterize the RNA-binding protein network that recognizes and suppresses TE mRNAs. These studies will provide new insight into brain-specific genome defense pathways and their relevance to neurological disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $415,250 )
2026	2026	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	6/18/2026	NEW	$415,250
														Subtotal = $415,250

Grand Total All Awards = $415,250

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanism of Transposon Silencing in the Brain

Award Number: R21NS145053

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/16/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer